BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 22412152)

  • 1. Population-based 20-year survival among people diagnosed with thin melanomas in Queensland, Australia.
    Green AC; Baade P; Coory M; Aitken JF; Smithers M
    J Clin Oncol; 2012 May; 30(13):1462-7. PubMed ID: 22412152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ten-Year Survival after Multiple Invasive Melanomas Is Worse than after a Single Melanoma: a Population-Based Study.
    Youlden DR; Baade PD; Soyer HP; Youl PH; Kimlin MG; Aitken JF; Green AC; Khosrotehrani K
    J Invest Dermatol; 2016 Nov; 136(11):2270-2276. PubMed ID: 27019458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of an additional in situ melanoma does not influence survival for patients with a single invasive melanoma: A registry-based follow-up study.
    Youlden DR; Khosrotehrani K; Green AC; Soyer HP; Kimlin MG; Youl PH; Aitken JF; Baade PD
    Australas J Dermatol; 2016 Feb; 57(1):57-60. PubMed ID: 26776229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanoma survival disadvantage in young, non-Hispanic white males compared with females.
    Gamba CS; Clarke CA; Keegan TH; Tao L; Swetter SM
    JAMA Dermatol; 2013 Aug; 149(8):912-20. PubMed ID: 23804160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis for patients with thin cutaneous melanoma: long-term survival data from New South Wales Central Cancer Registry and the Sydney Melanoma Unit.
    McKinnon JG; Yu XQ; McCarthy WH; Thompson JF
    Cancer; 2003 Sep; 98(6):1223-31. PubMed ID: 12973846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanoma survival is superior in females across all tumour stages but is influenced by age.
    Khosrotehrani K; Dasgupta P; Byrom L; Youlden DR; Baade PD; Green AC
    Arch Dermatol Res; 2015 Oct; 307(8):731-40. PubMed ID: 26103951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma.
    Murali R; Haydu LE; Long GV; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Kefford RF; Thompson JF; Scolyer RA
    Ann Surg Oncol; 2012 Jun; 19(6):1782-9. PubMed ID: 22350600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors related to the presentation of thin and thick nodular melanoma from a population-based cancer registry in Queensland Australia.
    Geller AC; Elwood M; Swetter SM; Brooks DR; Aitken J; Youl PH; Demierre MF; Baade PD
    Cancer; 2009 Mar; 115(6):1318-27. PubMed ID: 19189368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of subsequent primary invasive melanomas following a first primary invasive or in situ melanoma Queensland, Australia, 1982-2010.
    Youlden DR; Youl PH; Soyer HP; Aitken JF; Baade PD
    JAMA Dermatol; 2014 May; 150(5):526-34. PubMed ID: 25093216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic subclassifications of T1 cutaneous melanomas based on ulceration, tumour thickness and Clark's level of invasion: results of a population-based study from the Swedish Melanoma Register.
    Lyth J; Hansson J; Ingvar C; Månsson-Brahme E; Naredi P; Stierner U; Wagenius G; Lindholm C;
    Br J Dermatol; 2013 Apr; 168(4):779-86. PubMed ID: 23066913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival outcomes in patients with multiple primary melanomas.
    Rowe CJ; Law MH; Palmer JM; MacGregor S; Hayward NK; Khosrotehrani K
    J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2120-7. PubMed ID: 25864459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical course of cutaneous melanoma of the head and neck, and the factors affecting patient survival].
    Tarkov SA; Mikhnin AE; Shelekhova KV; Frolova OS; Nefedov AO
    Vopr Onkol; 2013; 59(1):114-7. PubMed ID: 23814837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival and Surgical Outcomes for Pediatric Head and Neck Melanoma.
    Richards MK; Czechowicz J; Goldin AB; Gow KW; Doski J; Goldfarb M; Nuchtern J; Langer M; Beierle EA; Vasudevan S; Gupta D; Parikh SR
    JAMA Otolaryngol Head Neck Surg; 2017 Jan; 143(1):34-40. PubMed ID: 27607058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002.
    Coory M; Baade P; Aitken J; Smithers M; McLeod GR; Ring I
    Cancer Causes Control; 2006 Feb; 17(1):21-7. PubMed ID: 16411049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is sex an independent prognostic factor in cutaneous head and neck melanoma?
    Arce PM; Camilon PR; Stokes WA; Nguyen SA; Lentsch EJ
    Laryngoscope; 2014 Jun; 124(6):1363-7. PubMed ID: 24122966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors of thin cutaneous melanoma: an analysis of the central malignant melanoma registry of the german dermatological society.
    Leiter U; Buettner PG; Eigentler TK; Garbe C
    J Clin Oncol; 2004 Sep; 22(18):3660-7. PubMed ID: 15302905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Competing risk analysis of mortality from invasive cutaneous melanoma in New South Wales: a population-based study, 1988-2007.
    Marashi-Pour S; Morrell S; Cooke-Yarborough C; Arcorace M; Baker D
    Aust N Z J Public Health; 2012 Oct; 36(5):441-5. PubMed ID: 23025365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiological features and prognostic factors of cutaneous head and neck melanoma: a population-based study.
    Golger A; Young DS; Ghazarian D; Neligan PC
    Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):442-7. PubMed ID: 17515502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lethal Melanomas: A Population-based Registry Study in Western Sweden from 1990 to 2014.
    Claeson M; Gillstedt M; Whiteman DC; Paoli J
    Acta Derm Venereol; 2017 Nov; 97(10):1206-1211. PubMed ID: 28761961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.
    Buettner PG; Leiter U; Eigentler TK; Garbe C
    Cancer; 2005 Feb; 103(3):616-24. PubMed ID: 15630700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.